Mr. Barry O'Leary:

The Deputy can take it that IDA Ireland is engaged with all of the biopharmaceutical companies worldwide, some of which, through the SEC filing, are already in the public arena, while many others are not, and is aware of active projects they may have. There is plenty of competition while we wait for companies to take the final step.